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CSN subunit isoformThe COP9 signalosome (CSN) is a regulator of the ubiquitin (Ub) proteasome system (UPS). It inter-
acts with hundreds of cullin-RING ubiquitin E3 ligases (CRLs) and regulates their activity by remov-
ing the Ub-like protein Nedd8 from cullins. In mammalian cells 7 different cullins exist which form
CRLs with adaptor proteins and with a large number of substrate recognition subunits such as F-box
and BTB proteins. This large variety of CRL-complexes is deneddylated by the CSN. The capacity of
the CSN to interact with numerous types of CRL complexes can be explained by its structural diver-
sity, which allows different CSN variants to interact with different binding partners and substrates
and enables different subunit expression proﬁles. Diversity of CSN complexes presumably occurs by:
(1) ﬂexibility of CSN holo complex structure; (2) formation of CSN mini complexes and free CSN sub-
units and (3) generation of CSN variants via integration of CSN subunit isoforms. In this review we
will discuss the structural diversity of the CSN complex and possible functional consequences.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Originally the COP9 signalosome (CSN) was puriﬁed and charac-
terized as a negative regulator of Constitutive Photomorphogenesis
(COP) in plants [1]. The identiﬁcation of the CSN in mammalian
cells revealed its structural homology with the 26S proteasome
Lid complex [2–4] and with the translation initiation complex 3
(eIF3) [5]. The three complexes CSN, Lid and eIF3, which are also
known as ZOMES, presumably have a common ancestor and con-
sist of Proteasome-COP9 signalosome-Initiation factor 3 (PCI)
domain as well as MOV34-Pad1-N-terminal (MPN) domain sub-
units [6,7]. The CSN is highly conserved in eukaryotes and has been
studied in many organisms such as Saccharomyces cerevisiae [8,9],
Schizosaccharomyces pombe [10], Aspergillus nidulans [11],
Caenorhabditis elegans [12], Drosophila melanogaster [13] and in
Arabidopsis thaliana [14,15]. In most organisms, the CSN complex
is comprised of eight subunits CSN1 to CSN8. It is a metallopro-
tease complex possessing a MPN+/JAMM motif, which belongs to
the JAMM family of deubiquitinating enzymes (DUBs). Its catalytic
center is localized on CSN5 and is responsible for the
CSN-mediated removal of Nedd8 from cullins, a process called
deneddylation [16]. Free CSN5 is inactive and requires structural
rearrangements in the CSN holo complex for activation and theformation of the Nedd8-binding pocket [17,18]. Recent kinetic
studies revealed that puriﬁed CSN is an efﬁcient and speciﬁc
enzyme in vitro possessing a kcat of approximately 1 s1 using
neddylated Cul1 as substrate [19,20].
The CSN is a regulator of the ubiquitin proteasome system (UPS)
and forms supercomplexes with cullin-RING ubiquitin (Ub) ligases
(CRLs), which comprise the largest family of Ub ligases with more
than 250 members [21,22]. In each CRL complex, one member of
the cullin family (Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5 and Cul7)
provides the scaffold [23]. The C-terminus of the respective cullin
binds a RING H2 ﬁnger protein, Rbx1 or Rbx2, which recruits the
E2 with the activated Ub. The N-termini of cullins bind
substrate-adaptor proteins (Skp1, elongin C or DDB1) that recruit
substrate-recognition subunits (SRSs) to the complex [24]. For
example, F-box proteins (FBP) function as SRS in case of Cul1 com-
plexes (CRL1) and BTB proteins for CRL3s [24,25]. The CSN dened-
dylates cullins, which results in the inactivation of CRLs [22,26,27].
Deneddylation is a prerequisite for CRL remodeling, which is
completed by the action of the protein exchange factor
Cullin-Associated and Neddylation-Dissociated 1 (CAND1)
[28–31]. By controlling the remodeling of CRL complexes the CSN
and CAND1 are essential for the adaptation of cells to changing
substrate-speciﬁcity requirements.
Besides binding to CRLs, the CSN is associated with protein
kinases CK2, PKD, and Akt as well as inositol 1,3,4-triphosphate
5/6 kinase [32–34]. The kinases speciﬁcally modify substrates of
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phorylate CSN2 and CSN7 [33,36]. Further proteins associated with
the CSN are the DUBs Ub-speciﬁc protease 15 (USP15) [37,38] and
USP48 [39] and deneddylating enzyme 1 (Den1) [40]. Whereas
USP15 seems to protect components of CRLs [37,41], interaction
with Den1 is accompanied with Den1 destabilization [40].
Moreover, CSN-associated USP15 and USP48 control CRL substrates
IjBa and RelA [39,42,43]. In collaboration with the UPS the CSN is
involved in cell cycle progression [14], DNA repair [14,44], cell dif-
ferentiation [45–48], development [15,45,47] as well as in tumori-
genesis [49,50]. The versatility of CSN function, i.e. the interaction
with this large number of CRLs as well as associated proteins can
be explained by the ﬂexibility of CSN structure and by the exis-
tence of different CSN variants. In this review we will focus on
structural diversity of CSN complexes and possible functional
consequences.
2. Flexibility of CSN structure revealed by X-ray and Cryo-EM
analyses
Initial structural analysis of the CSN complex was published in
2000, where the puriﬁed complex from human erythrocytes was
studied using negative stain electron microscopy (EM) [36]. Later,
the subunit topology of the recombinant human CSN was investi-
gated by structural mass spectrometry (MS) approaches [51].
Additional progress was made by EM and single particle analysis,
which generated a three-dimensional (3D) molecular model for
the recombinant CSN [52,53] in which subunit locations were pre-
dicted on the basis of comparison with homologs in the Lid [54,55].
In our recent 3D model derived from Cryo-EM analysis of isolated
native, human CSN complexes the spatial arrangement of CSN sub-
units can be estimated [20]. This structural 3D model was recently
completed by X-ray crystallography of the human recombinant
CSN [17] (see Fig. 1). The alignment of the Cryo-EM structure and
the X-ray structure in Fig. 1 demonstrates the conformity of the
two 3D structures obtained with different methods. Already the
initial EM studies determined four major classes of the nativeFig. 1. Comparison of CSN 3D models obtained by Cryo-EM [20] and X-ray [17] analysis.
with recombinant human CSN. In the X-ray structure CSN subunits are illustrated in diff
the Cryo-EM structure.CSN suggesting conformational variability of the complex. The esti-
mated CSN diameter of approximately 140–150 Å [36] is in accor-
dance with recent data [17,20]. Cryo-EM and X-ray crystallography
in detail conﬁrmed that PCI domains of all PCI domain subunits
form a horseshoe-shaped structure in the order of CSN7, CSN4,
CSN2, CSN1, CSN3 and CSN8 (see Fig. 1). The N-terminal helical
repeat domains of the PCI proteins radiate from the horseshoe
forming arm-like protrusions [17,20]. Interestingly, the analysis
of native CSN complexes by Cryo-EM revealed structural variety
in the shape of the horseshoe [20]. One might speculate, therefore,
that the horseshoe is a ﬂexible structure and post translational
modiﬁcation like phosphorylation might inﬂuence its
conformation.
Another important structural element of the CSN is the helical
bundle formed by the C-terminal helices of all subunits (see
Fig. 1). CSN6 has three C-terminal helices and interacts with every
other subunit in the center of the bundle [17]. The MPN domains of
CSN5 and CSN6 form a heterodimer that rests on the helical bundle
and generates a protrusion on the side opposite the PCI subunits
[17,20]. CSN5 has a unique peripheral position in the complex
and presumably can leave the subunit assembly without dis-
turbing the rest of the complex. Some cells contain CSN5-free
CSN complexes [56,57]. On the other hand, CSN5 can be incorpo-
rated into a CSN5-free CSN and the result is a catalytically active
complex [17]. Modeling of CSN–CRL interactions revealed
substrate-induced structural dynamics associated with activation.
While in the absence of the substrate (neddylated cullin) CSN5 is
in an inactive conformation, substrate binding leads to a dramatic
domain motion of CSN4, which moves the CSN5–CSN6 dimer away
from the helical bundle and yields an active CSN [17]. In addition,
there is a stable interaction between CSN2 and cullin 1, where
N-terminal helical repeat units of CSN2 embrace the cullin 1
C-terminal arm [17,53]. Based on these observations it is reason-
able to assume that the N-termini of the PCI domain subunits,
especially CSN4, are ﬂexible structures and important for CSN–
CRL binding and that possible modiﬁcations of these structures
might inﬂuence protein–protein interactions. The helical bundleCryo-EM was carried out with native human CSN and X-ray analysis was performed
erent colors. Localizations of the Horseshoe and of the Helical Bundle are indicated in
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involved in conformational changes regulating CSN activity in
response to phosphorylation. Interestingly, a complete dephospho-
rylation of the native CSN led to a block of deneddylating activity.
More studies are required to reveal the impact of speciﬁc phospho-
rylation on CSN structure and activity.Fig. 2. Formation of putative CSN mini complexes and the release of free CSN5 from
the CSN holo complex. The CSN mini complexes CSN1/2/3/8, CSN4/5/6/7 and CSN4/
5/6/7/8 are described in detail in the text.3. CSN mini complexes and free CSN subunits
3.1. CSN mini complexes and their possible functions
CSN mini complexes are composed of a reduced number of
canonical CSN subunits possessing different functions as the CSN
holo complex. First indication of the existence of CSN mini com-
plexes came from genetic data. For example, in S. pombe knockouts
of CSN subunits are viable. However, csn1 and csn2 knockouts, but
not knockouts of other subunits, displayed a delay in S phase [10].
This observation led to the assumption of a CSN1–CSN2 mini com-
plex with distinct function [58]. However, this complex was never
identiﬁed. In addition, Drosophila null mutations of CSN4 and CSN5
are characterized by both shared and unique phenotypes. This
might indicate speciﬁc roles for CSN4 and CSN5 besides their func-
tion in the CSN holo complex and possible CSN mini complexes
containing CSN4 and CSN5 were detected [59]. On the other hand,
phenotypic differences between CSN subunit knockouts may be
also attributed to specialized roles of individual CSN subunits
within the CSN holo complex. In higher eukaryotic cells the CSN
as well as the 26S proteasome Lid are essential complexes.
Therefore mini complexes comprising only subsets of the canonical
subunits and incapable of compensating the function of the holo
complex can only exist in addition to the holo complex, if at all.
The expression of CSN subunits is coordinated by miRNAs of the
let-7 family leading to the assembly of holo complexes [60].
Thus, the formation of putative CSN mini complexes requires
destruction either of this ﬁne-tuning mechanism or of already
assembled CSN holo complexes. For example, mini complexes
might occur, if miRNA control is disturbed and a subset of subunits
is permanently overexpressed in an uncoordinated manner.
Another formation route for mini complexes might be the disinte-
gration of the holo complex. Mini complexes have been obtained
in vitro by structural mass spectrometry revealing CSN1/2/3/8
and CSN4/5/6/7 (see Fig. 2) from recombinant human CSN [51]
or by coexpression in a bacterial reconstitution system [61], which,
however, were never detected in cells so far (see Fig. 2). Also, the
crystal and the Cryo-EM structures of the CSN (see above) do not
indicate a distinct bi-modular construction of the CSN. Based on
the interpretation of glycerol gradients, pulldowns and CSN sub-
unit overexpression the existence of a CSN4–8 mini complex was
postulated (see Fig. 2). It is mostly localized in the cytoplasm of
mouse ﬁbroblasts and is involved in p27 downregulation [62].
Later, a so far uncharacterized ‘‘small’’ Jab1/CSN5 complex has
been detected by immunoblotting and assumed to be involved in
cell cycle regulation [63]. Recently it has been shown that in
NIH3T3 cells free CSN5 interacts with CDK2, presumably control-
ling premature senescence [64]. Whether CSN5–CDK2 is the
sought-after CSN mini complex is not clear at the moment. It is
noteworthy mentioning that to our knowledge nothing has been
published on any mini complexes derived from the 26S protea-
some Lid complex in higher eukaryotic cells.
3.2. Free CSN subunits and their putative functions
All subunits of the CSN are initially produced in free form before
they assemble into the holo complex in a coordinated manner.
Although at the moment the assembly mechanism of CSN is poorlyunderstood, it can be speculated that it is similar to the ordered
assembly directed by the helical bundle, which was suggested for
the 26S proteasome Lid [65]. In case of the CSN, and probably also
of the Lid, subunit expression prior to the assembly is ﬁne-tuned
by miRNAs [60]. Normally, the steady state levels of free CSN sub-
units are not detectable by immunoblotting. However, there are
cases when protein levels of CSN subunits increase in a coordi-
nated manner and de novo formation of CSN complexes occurs.
Such an increase of CSN complex formation has been observed
after overexpression of CSN1 or CSN3 [60] and in response to
DNA damage induced by Mitomycin C [66]. A coordinated decline
of the amount of the CSN protein complex seems to be the reason
for the Smith–Magenis syndrome, where a hemizygously deletion
of CSN3 occurred [67]. This assumption is supported by the
observed reduction of the concentration of CSN complexes in cell
cultures when CSN3 was downregulated [56]. Apparently, CSN5
is different. Its silencing to 10–20% does not destroy the rest of
the complex, whereas downregulation of CSN1 or CSN3 to levels
below 40% is connected with the destruction of the CSN and cell
death [56,57,60]. Presumably, cells always contain CSN5-free CSN
complexes [56,57], which might be involved in blocking CRL activ-
ities [53]. Structural analyses revealed CSN5 as a peripheral sub-
unit that obviously can be released from and reenter the
seven-subunit CSN (see Fig. 2) (see above). At the moment it is
unclear whether this process plays a regulatory role and whether
the remaining seven-subunit CSN or free CSN5 possess functions
on their own. In fact, free CSN5 is unable to cleave the isopeptide
bond between cullin and Nedd8 [16] due to its conformation in
which the so called Ins-1 loop blocks access to the substrate bind-
ing site [18]. Adding recombinant free CSN5 to native CSN complex
in vitro has no impact on the CSN deneddylating activity with
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to cellular components (see above) might interfere with essential
cellular processes. An overexpression of CSN5 has been detected
in a variety of human tumors (for review see [49]). However, in
most of these studies the expression of other CSN subunits besides
CSN5 was not analyzed on the protein level. Therefore, it is unclear
whether these tumor cells are characterized by an increase of free
CSN5 or of the CSN holo complex.
The release of CSN6 from the CSN holo complex is unlikely,
because it is tightly integrated into the complex [17]. Thus, the
removal of CSN6 would lead to the loss of the structural integrity
of the CSN [68]. An uncontrolled overexpression of CSN6 is also
unlikely, since CSN expression is ﬁne-tuned by miRNAs [60] and
a mutation that suspends this control has not been reported, yet.
To our knowledge free CSN6 can be hardly detected under cell cul-
ture conditions. Nevertheless, there are attempts to ascribe a dis-
crete function to free CSN6, for example a role in regulating the
stability of Mdm2 [50], p57 [69] and Myc [70]. In these experi-
ments, CSN6 was artiﬁcially overexpressed and its expression
was not correlated with the expression of other CSN subunits.
The observations can be partially interpreted as functions of the
holo CSN. CSN7, most likely as part of the CSN holo complex, has
been suggested to act as a co-regulator of transcription by binding
to multiple genomic loci [71]. Free CSN7 has not been detected in
cells so far. Likewise, removal of subunit CSN4 from the holo CSN
complex is very unlikely. Nevertheless, it acts as switch from
self-renewal to differentiation of germline stem cells [72].
Alien, a version of CSN2, acts as a corepressor independently of
the CSN. It represses cell proliferation and interacts with regulators
like CREB-binding protein [73,74].
In conclusion, so far there are no data on the existence and func-
tion of CSN mini complexes in vivo. Moreover, CSN5 seems to be
the only free CSN subunit which might occur under certain circum-
stances in certain cells. However, whether it exhibits any speciﬁc
function has to be conﬁrmed in the future.4. CSN variants and their functions
The diversity of CSN complex composition becomes obvious
when CSN particles from different eukaryotic organisms are com-
pared. The S. cerevisiae CSN (ScCSN) is the most divergent CSN.
The ScCSN complex includes only 6 ortholog subunits:
CSN1/CSN11/Pci8, CSN2/CSN10, CSN4/Rpn5 (shared subunit with
the Lid), CSN5/Rri1, CSN6/Csi1 and CSN7/CSN9. In spite of this
lower number of subunits it is able to deneddylate mammalian
CRLs [68,75]. In S. pombe subunits CSN6 and CSN8 are missing.
Thus, SpCSN is composed of 6 subunits including CSN7A, whereas
CSN7B is a subunit of the eIF3 complex [76]. In A. nidulans the
canonical eight-subunit CSN has been detected [77], while in
Neurospora crassa CSN8 is missing [78]. The C. elegans CSN shares
CSN7/CIF-1 with the eIF3 complex and CSN8 is missing [79]. CSN
variants containing CSN subunit isoforms have been described in
plants and in mammals.
4.1. CSN variants created by CSN subunit isoforms
4.1.1. CSN subunit isoforms originated from gene duplications
In Arabidopsis, CSN5 is encoded by two homologous genes,
CSN5A and CSN5B [80]. In addition, CSN6, the other MPN domain
protein missing the MPN+/JAMM domain, is also encoded by two
genes in Arabidopsis, CSN6A and CSN6B [81]. While mutants lacking
one of the homologous CSN5A and CSN5B or CSN6A and CSN6B
genes are viable, the knockout of both homologous genes results
in the typical lethal phenotype known for CSN subunit knockouts
[57,81,82]. This indicates that CSN5A and CSN5B as well asCSN6A and CSN6B have overlapping functions. Amino acid
sequences of CSN5A and CSN5B possess 86% and CSN6A and
CSN6B 87% sequence identity [83]. The CSN5 and the CSN6 iso-
forms assemble into distinct CSN complexes [81,82] and various
CSN populations composed of different combinations of isoforms
might exist in plants (see Fig. 3A). It has been demonstrated that
CSN6A and CSN6B have mostly similar functions, whereas CSN5A
and CSN5B seem to play unique roles in plant development [81].
Both CSNCSN5A and CSNCSN5B possess deneddylating activity and
can partially compensate for each other. However, the two iso-
forms differ in their functionality. For example, CSN5B, but not
CSN5A, directly interacts with, VTC1, a key enzyme for the produc-
tion of vitamine C [84]. In csn5b mutants VTC1 is stabilized and
vitamine C accumulates. Therefore, it is possible that CSNCSN5A
and CSNCSN5B carry out unequal functions by binding to different
target proteins. In addition, the two genes CSN5A and CSN5B show
different expression patterns [83]. The expression of CSN5B is con-
sistently higher in roots than in leaves, whereas CSN5A expression
is similar in roots and in leaves. Interestingly, according to expres-
sion proﬁles CSNCSN5B most likely has an important role in seed
development [83].
Little is known about CSN7A and CSN7B expression proﬁles or
functions of CSNCSN7A and CSNCSN7B complexes in mammalian cells
(see Fig. 3B). Mass spectrometry analysis revealed the coexistence
of endogenous CSNCSN7A and CSNCSN7B complexes in human red
blood cells [85,86]. Moreover, coexpression of CSN7A and CSN7B
has been shown in other mammalian cells as well [3]. Human
CSN7A and CSN7B genes are a result of gene duplication. The
encoded proteins possess a sequence identity of 59%.
Pulldown analysis revealed that CSNCSN7A and CSNCSN7B com-
plexes are composed of a complete set of CSN subunits and exhib-
ited different afﬁnities to CRL components and to the CSN
associated protein USP15. Adipogenesis induced in LiSa-2 cells
[48] showed that permanent expression of Flag-CSN7B causes
accelerated adipogenesis as compared to cells expressing
Flag-CSN7A. We conclude that CSNCSN7A and CSNCSN7B complexes
have different functions in adipocyte differentiation. Additional
studies are necessary to elucidate CSN7A and B functions.
4.1.2. CSN8 isoforms originated from alternative translation initiation
sites
Although CSN8 is encoded by a single gene it appears as a typ-
ical doublet band in SDS–PAGE as shown for mouse, porcine and
human CSN8 [3,87]. It has been concluded that the two CSN8 iso-
forms arise from alternative translation initiation sites at Met1
(CSN8A) and Met6 (CSN8B) [87]. Mass spectrometry analysis con-
ﬁrmed the two alternative translation initiation sites and revealed
that CSN8A as well as CSN8B are integrated into distinct CSN com-
plexes (see Fig. 3C). For the CSN puriﬁed from human red blood
cells it was determined that only 25% of the total CSN population
contained CSN8B, while the majority of CSN complexes contained
CSN8A [85]. At the moment nothing is known about functions of
CSN8A and CSN8B.
4.2. CSN variants made by other modiﬁcations of CSN subunits
Post-translational modiﬁcations (PTMs) including ubiquitina-
tion, neddylation, sumoylation and phosphorylation might create
additional CSN variants. Although nothing is known so far about
ubiquitination, neddylation or sumoylation, several studies have
indicated that CSN subunits are phosphorylated by associated or
other kinases [33,36,88]. Most prominent phosphorylated subunits
are CSN1 [89,90], CSN2 [33] and CSN7 [33,91]. Likewise, CSN3 and
CSN8 were shown to be phosphorylation targets of GSK3b kinase
[89,92]. Moreover, CSN1, CSN3, CSN7 and CSN8 undergo phospho-
rylation in response to DNA damage [90,93,94]. The function of
Fig. 3. CSN variants formed by CSN subunit isoforms. (A) Arabidopsis CSN variants composed of different isoforms of CSN5 and CSN6 subunits. (B) Mammalian CSN variants
composed of CSN7A and CSN7B isoforms. (C) Isoforms of CSN8, CSN8A and CSN8B, are integrated into different CSN variants. A combination of CSN7 and CSN8 isoforms as it is
shown for Arabidopsis CSN5 and CSN6 in (A) is very likely.
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such PTMs inﬂuence the CSN function, deneddylating activity,
localization and protein–protein interactions. Due to limited
experimental data, today we do not know any PTM that creates a
speciﬁc CSN variant.
5. Conclusions and perspectives
Diversiﬁcation of CSN complexes during evolution is an adapta-
tion process which allows the protein complex to bind different
substrates as well as interacting partners and to meet the demands
of various conditions in different cells. One way to increase CSN
diversity is most likely the ﬂexibility of the CSN structure which
can be modiﬁed by PTMs to produce CSN complexes with different
activities. The function of CSN mini complexes and free CSN sub-
units is still under debate and has to be veriﬁed in the future.
The existence of CSN subunit isoforms and their integration into
distinct CSN variants has been demonstrated for plant and mam-
malian cells. This form of diversiﬁcation increases the number of
possible cellular CSN variants and allows differential expression
proﬁles of the isoforms during developmental and differentiation
processes. More work is necessary to understand the overlappingand the unique roles of different CSN variants. So far nothing is
known about the switch from one to another CSN variant and its
regulation.
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